The FDA’s vaccine advisory group will discuss the make-up of 2024-25 vaccines at its meeting on May 16.
WHO COVID vaccine advisers recommend switch to JN.1 strain
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Long-COVID codes in health record may dramatically underestimate its prevalence
- Quick takes: School infection prevention, low US respiratory virus levels, polio in 3 nations
- Study: Kids with long COVID have impaired exercise capacity
- Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients